RU2008117168A - Системы, устройства и способы для чрезкожной доставки лекарств, использующие опиоидный агонист и/или опиоидный антагонист - Google Patents

Системы, устройства и способы для чрезкожной доставки лекарств, использующие опиоидный агонист и/или опиоидный антагонист Download PDF

Info

Publication number
RU2008117168A
RU2008117168A RU2008117168/14A RU2008117168A RU2008117168A RU 2008117168 A RU2008117168 A RU 2008117168A RU 2008117168/14 A RU2008117168/14 A RU 2008117168/14A RU 2008117168 A RU2008117168 A RU 2008117168A RU 2008117168 A RU2008117168 A RU 2008117168A
Authority
RU
Russia
Prior art keywords
opioid antagonist
opioid
solvates
pharmaceutical composition
pain
Prior art date
Application number
RU2008117168/14A
Other languages
English (en)
Russian (ru)
Inventor
Даррик КАРТЕР (US)
Даррик КАРТЕР
Original Assignee
ТиТиАй ЭЛЛЕБО, ИНК. (JP)
ТиТиАй Эллебо, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ТиТиАй ЭЛЛЕБО, ИНК. (JP), ТиТиАй Эллебо, Инк. filed Critical ТиТиАй ЭЛЛЕБО, ИНК. (JP)
Publication of RU2008117168A publication Critical patent/RU2008117168A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
RU2008117168/14A 2005-09-30 2006-09-29 Системы, устройства и способы для чрезкожной доставки лекарств, использующие опиоидный агонист и/или опиоидный антагонист RU2008117168A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72213605P 2005-09-30 2005-09-30
US60/722,136 2005-09-30

Publications (1)

Publication Number Publication Date
RU2008117168A true RU2008117168A (ru) 2009-11-10

Family

ID=37696075

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008117168/14A RU2008117168A (ru) 2005-09-30 2006-09-29 Системы, устройства и способы для чрезкожной доставки лекарств, использующие опиоидный агонист и/или опиоидный антагонист

Country Status (10)

Country Link
EP (1) EP1931421A1 (https=)
JP (1) JP2009509692A (https=)
KR (1) KR20080058433A (https=)
CN (2) CN101316623A (https=)
AU (1) AU2006299521A1 (https=)
BR (1) BRPI0616788A2 (https=)
CA (1) CA2622684A1 (https=)
IL (1) IL190245A0 (https=)
RU (1) RU2008117168A (https=)
WO (1) WO2007041544A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100239523A1 (en) * 2007-10-30 2010-09-23 The Regents Of The University Of Colorado Tlr modulators and methods for using the same
EP2278966B1 (en) 2008-03-21 2019-10-09 The University of Chicago Treatment with opioid antagonists and mtor inhibitors
US8691768B2 (en) 2008-05-01 2014-04-08 The Regents Of The University Of California Methods of determining delta opioid receptor subtypes
JP4779084B2 (ja) * 2009-03-25 2011-09-21 国立大学法人 香川大学 マイクロニードルおよびその製造方法と金型
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
CN106730311B (zh) * 2016-12-27 2019-10-29 潍坊大地医疗器械有限公司 经络综合治疗仪电极触头装置
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy
WO2019090125A2 (en) * 2017-11-02 2019-05-09 Chrono Therapeutics Inc. Smart abuse-deterrent transdermal drug delivery system
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
ES3011582T3 (en) 2019-02-21 2025-04-07 Pharmaceutical Productions Inc Naloxone formulations for sublingual and/or buccal administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US5312326A (en) * 1992-06-02 1994-05-17 Alza Corporation Iontophoretic drug delivery apparatus
SI1646328T1 (sl) * 2003-07-25 2008-02-29 Euro Celtique Sa Zdravljenje pri odvajanju od odvisnosti
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential

Also Published As

Publication number Publication date
AU2006299521A1 (en) 2007-04-12
KR20080058433A (ko) 2008-06-25
CN101316623A (zh) 2008-12-03
IL190245A0 (en) 2008-11-03
CN101321554A (zh) 2008-12-10
CA2622684A1 (en) 2007-04-12
BRPI0616788A2 (pt) 2011-07-05
EP1931421A1 (en) 2008-06-18
WO2007041544A1 (en) 2007-04-12
JP2009509692A (ja) 2009-03-12

Similar Documents

Publication Publication Date Title
RU2008117168A (ru) Системы, устройства и способы для чрезкожной доставки лекарств, использующие опиоидный агонист и/или опиоидный антагонист
US5149538A (en) Misuse-resistive transdermal opioid dosage form
US8481560B2 (en) Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
JP2009509692A5 (https=)
RU98102450A (ru) Способ эпидурального введения терапевтических соединений с поддерживаемой скоростью высвобождения, способ уменьшения угнетения дыхания
JP2010189403A5 (https=)
CA2868413C (en) Systems and methods for treating an opioid-induced adverse pharmacodynamic response
EP2056825B1 (en) Use of opioid formulations in needle-less drug delivery devices
CA2569742A1 (en) Opioids for the treatment of the restless leg syndrome
US20200276187A1 (en) Systems and methods for attenuating opioid-induced euphoria
US10226457B2 (en) Systems and methods for treating an opioid-induced adverse pharmacodynamic response
RU2012124063A (ru) Лекарственная комбинация с теобромином и ее использование в лечении
KR20180074797A (ko) 통증 치료를 위한 오피오이드 작용제 및 오피오이드 길항제의 비-경피 전달된 n-옥시드 유도체를 포함하는 남용 방지 경피 전달 장치 및 조성물
US20100317682A1 (en) Single Dosage Unit Including Opioid and Methylnaltrexone or Methylnaltrexone Salt
MX2008004223A (en) Transdermal drug delivery systems, devices, andmethods employing opioid agonist and/or opioid antagonist